|
|
||||||||
Department of Microbiology and Immunology and The Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202; and The Walther Cancer Institute, Indianapolis, IN 46208
The B cell lymphoma-6 (BCL-6) transcriptional repressor protein is an important regulator of B cell differentiation and is strongly implicated in the development of B cell lymphoma. Expression of the Blimp-1 transcription factor, which is critical for promoting B cell differentiation into plasma cells, is repressed by BCL-6. We have investigated the mechanism for how BCL-6 represses Blimp-1 transcription, and have found that BCL-6 regulates the Blimp-1 promoter through a novel mechanism involving AP-1 elements. Specifically, BCL-6 is a potent repressor of transcriptional activity mediated by AP-1 factors. We found that the zinc-finger region of BCL-6 interacts with c-Jun, JunB, and JunD proteins but does not bind c-Fos or Fra-2 proteins. An estrogen receptor ligand binding domain fusion with the BCL-6 zinc finger domain can act as a estrogen-inducible dominant negative protein and increase AP-1 activity in BCL-6+ cells but not in BCL-6- cells, indicating that endogenous BCL-6 represses AP-1 activity. Additionally, we have confirmed a specific interaction between c-Jun and the zinc finger domain of BCL-6 in vivo using a mammalian two-hybrid assay. Repression of AP-1 function by BCL-6 may be a key mechanism for how BCL-6 regulates gene expression to control inflammation, lymphocyte differentiation, and lymphomagenesis.
This article has been cited by other articles:
![]() |
S. Desai, S. C. E. Bolick, M. Maurin, and K. L. Wright PU.1 Regulates Positive Regulatory Domain I-Binding Factor 1/Blimp-1 Transcription in Lymphoma Cells J. Immunol., November 1, 2009; 183(9): 5778 - 5787. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wei, K. Zaprazna, J. Wang, and M. L. Atchison PU.1 Can Recruit BCL6 to DNA To Repress Gene Expression in Germinal Center B Cells Mol. Cell. Biol., September 1, 2009; 29(17): 4612 - 4622. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saito, U. Novak, E. Piovan, K. Basso, P. Sumazin, C. Schneider, M. Crespo, Q. Shen, G. Bhagat, A. Califano, et al. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma PNAS, July 7, 2009; 106(27): 11294 - 11299. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ci, J. M. Polo, L. Cerchietti, R. Shaknovich, L. Wang, S. N. Yang, K. Ye, P. Farinha, D. E. Horsman, R. D. Gascoyne, et al. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL Blood, May 28, 2009; 113(22): 5536 - 5548. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schneider, M. A. Manzan, B. S. Yoo, R. B. Crawford, and N. Kaminski Involvement of Blimp-1 and AP-1 Dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated Suppression of the IgM Response by B Cells Toxicol. Sci., April 1, 2009; 108(2): 377 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, N. van Panhuys, J. Hu-Li, S. Kim, G. Le Gros, and B. Min Blimp-1 Induced by IL-4 Plays a Critical Role in Suppressing IL-2 Production in Activated CD4 T Cells J. Immunol., October 15, 2008; 181(8): 5249 - 5256. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schmidlin, S. A. Diehl, M. Nagasawa, F. A. Scheeren, R. Schotte, C. H. Uittenbogaart, H. Spits, and B. Blom Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression Blood, September 1, 2008; 112(5): 1804 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Polo, W. Ci, J. D. Licht, and A. Melnick Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells Blood, August 1, 2008; 112(3): 644 - 651. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Mendez, J. M. Polo, J. J. Yu, M. Krupski, B. B. Ding, A. Melnick, and B. H. Ye CtBP Is an Essential Corepressor for BCL6 Autoregulation Mol. Cell. Biol., April 1, 2008; 28(7): 2175 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ochiai, A. Muto, H. Tanaka, S. Takahashi, and K. Igarashi Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6 Int. Immunol., March 1, 2008; 20(3): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Ding, J. J. Yu, R. Y.-L. Yu, L. M. Mendez, R. Shaknovich, Y. Zhang, G. Cattoretti, and B. H. Ye Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas Blood, February 1, 2008; 111(3): 1515 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mora-Lopez, E. Reales, J. A. Brieva, and A. Campos-Caro Human BSAP and BLIMP1 conform an autoregulatory feedback loop Blood, November 1, 2007; 110(9): 3150 - 3157. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Parekh, J. M. Polo, R. Shaknovich, P. Juszczynski, P. Lev, S. M. Ranuncolo, Y. Yin, U. Klein, G. Cattoretti, R. D. Favera, et al. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms Blood, September 15, 2007; 110(6): 2067 - 2074. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Igarashi, K. Ochiai, and A. Muto Architecture and Dynamics of the Transcription Factor Network that Regulates B-to-Plasma Cell Differentiation J. Biochem., June 1, 2007; 141(6): 783 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ochiai, Y. Katoh, T. Ikura, Y. Hoshikawa, T. Noda, H. Karasuyama, S. Tashiro, A. Muto, and K. Igarashi Plasmacytic Transcription Factor Blimp-1 Is Repressed by Bach2 in B Cells J. Biol. Chem., December 15, 2006; 281(50): 38226 - 38234. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rui, J. I. Healy, J. Blasioli, and C. C. Goodnow ERK Signaling Is a Molecular Switch Integrating Opposing Inputs from B Cell Receptor and T Cell Cytokines to Control TLR4-Driven Plasma Cell Differentiation J. Immunol., October 15, 2006; 177(8): 5337 - 5346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Gearhart, C. M. Corcoran, J. A. Wamstad, and V. J. Bardwell Polycomb Group and SCF Ubiquitin Ligases Are Found in a Novel BCOR Complex That Is Recruited to BCL6 Targets. Mol. Cell. Biol., September 1, 2006; 26(18): 6880 - 6889. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Cooper, R. M. Karp, E. J. Clark, N. R. Taghizadeh, J. G. Hoyt, M. T. Labenski, M. J. Murray, G. Hannig, W. F. Westlin, and C. D. Thompson A Novel Methionine Aminopeptidase-2 Inhibitor, PPI-2458, Inhibits Non-Hodgkin's Lymphoma Cell Proliferation In vitro and In vivo Clin. Cancer Res., April 15, 2006; 12(8): 2583 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shapiro-Shelef, K.-I Lin, D. Savitsky, J. Liao, and K. Calame Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow J. Exp. Med., December 5, 2005; 202(11): 1471 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Miles, D. K. Crockett, M. S. Lim, and K. S. J. Elenitoba-Johnson Analysis of BCL6-interacting Proteins by Tandem Mass Spectrometry Mol. Cell. Proteomics, December 1, 2005; 4(12): 1898 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohkubo, M. Arima, E. Arguni, S. Okada, K. Yamashita, S. Asari, S. Obata, A. Sakamoto, M. Hatano, J. O-Wang, et al. A Role for c-fos/Activator Protein 1 in B Lymphocyte Terminal Differentiation J. Immunol., June 15, 2005; 174(12): 7703 - 7710. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Corcoran, J. Hasbold, W. Dietrich, E. Hawkins, A. Kallies, S. L. Nutt, D. M. Tarlinton, P. Matthias, and P. D. Hodgkin Differential requirement for OBF-1 during antibody-secreting cell differentiation J. Exp. Med., May 2, 2005; 201(9): 1385 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Wang, H. Sato, S. Kusam, S. Sehra, L. M. Toney, and A. L. Dent Regulation of IL-10 Gene Expression in Th2 Cells by Jun Proteins J. Immunol., February 15, 2005; 174(4): 2098 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Y.-L. Yu, X. Wang, F. J. Pixley, J. J. Yu, A. L. Dent, H. E. Broxmeyer, E. R. Stanley, and B. H. Ye BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production Blood, February 15, 2005; 105(4): 1777 - 1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Troen, V. Nygaard, T.-K. Jenssen, I. M. Ikonomou, A. Tierens, E. Matutes, A. Gruszka-Westwood, D. Catovsky, O. Myklebost, G. Lauritzsen, et al. Constitutive Expression of the AP-1 Transcription Factors c-jun, junD, junB, and c-fos and the Marginal Zone B-Cell Transcription Factor Notch2 in Splenic Marginal Zone Lymphoma J. Mol. Diagn., November 1, 2004; 6(4): 297 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tunyaplin, A. L. Shaffer, C. D. Angelin-Duclos, X. Yu, L. M. Staudt, and K. L. Calame Direct Repression of prdm1 by Bcl-6 Inhibits Plasmacytic Differentiation J. Immunol., July 15, 2004; 173(2): 1158 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Szremska, L. Kenner, E. Weisz, R. G. Ott, E. Passegue, M. Artwohl, M. Freissmuth, R. Stoxreiter, H.-C. Theussl, S. B. Parzer, et al. JunB inhibits proliferation and transformation in B-lymphoid cells Blood, December 1, 2003; 102(12): 4159 - 4165. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takeda, M. Arima, N. Tsuruoka, S. Okada, M. Hatano, A. Sakamoto, Y. Kohno, and T. Tokuhisa Bcl6 Is a Transcriptional Repressor for the IL-18 Gene J. Immunol., July 1, 2003; 171(1): 426 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Underhill, D. George, E. G. Bremer, and G. S. Kansas Gene expression profiling reveals a highly specialized genetic program of plasma cells Blood, May 15, 2003; 101(10): 4013 - 4021. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |